Status: Recruiting
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
This phase 2a trial is an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of one single intra-articular (IA) injection of 4P004 or placebo in: * patients between 40 and 80 years of age, * with synovitis and grade 2 to 4 osteoarthritis (OA) of the knee according to Kellgren and Lawrence (KL) classification.
Participants needed: 129
Trial details
Phase: Phase 2Age: 40-80Biological sex: AllType: InterventionalSponsor: 4Moving BiotechUpdated: Apr 14, 2026Locations: 22
Eligibility criteria
Participants who have the capacity to give informed consent and who are willing... [+16]
Pregnant or breastfeeding women. [+30]